ArticleExperimental and therapeutic medicine2017

Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway.

Wei Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.